Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis.

PURPOSE To evaluate the diagnostic value of 18F-FDG PET/CT for detection of bone metastasis in comparison with the efficacies of 18F-FDG PET/CT, CT, 18F-FDG PET and conventional planar bone scintigraphy in a series of cancer patients. METHODS Five hundred and thirty patients who underwent both 18F-FDG PET/CT and bone scintigraphy within 1 month were retrospectively analyzed. The skeletal system was classified into 10 anatomic segments and interpreted blindly and separately. For each modality, the sensitivity, specificity, accuracy, PPV and NPV were calculated and the results were statistically analyzed. RESULTS Bone metastases were confirmed in 117 patients with 459 positive segments. On patient-based analysis, the sensitivity, specificity, accuracy, PPV and NPV of 18F-FDG PET/CT were significantly higher than bone scintigraphy, CT and 18F-FDG PET (P<0.05). On segment-based analysis, the sensitivity of CT, bone scintigraphy, 18F-FDG PET and 18F-FDG PET/CT were 70.4%, 89.5%, 89.1% and 97.8%, respectively (P<0.05, compared with 18F-FDG PET/CT). The overall specificity and accuracy of the four modalities were 89.1%, 91.8%, 90.3%, 98.2% and 90.3%, 90.9%, 89.8%, 98.0%, respectively (P<0.05, compared with 18F-FDG PET/CT). The PPV and NPV were 89.8%, 87.6%, 85.6%, 97.2% and 85.6%, 93.2%, 92.8%, 98.6%, respectively. Three hundred and twelve lesions or segments were presented as lytic or sclerotic changes on CT images at the corresponding sites of increased 18F-FDG uptake. In lytic or mixed lesions, the sensitivity of 18F-FDG PET/CT and 18F-FDG PET were better than bone scintigraphy, while in osteoblastic lesions bone scintigraphy had a similar performance with 18F-FDG PET/CT but better than 18F-FDG PET alone. CONCLUSION Our data allow the conclusion that 18F-FDG PET/CT is superior to planar bone scintigraphy, CT or 18F-FDG PET in detecting bone metastasis. 18F-FDG PET/CT may enhance our diagnosis of tumor bone metastasis and provide more information for cancer treatment.

[1]  Ji-An Liang,et al.  Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. , 2013, European journal of radiology.

[2]  A. Loft,et al.  The diagnostic and prognostic value of 18F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  Takeo Ishigaki,et al.  Comparison of 18F-FDG PET and Bone Scintigraphy in Detection of Bone Metastases of Thyroid Cancer , 2007, Journal of Nuclear Medicine.

[4]  Yoon Jung Kang,et al.  The Effects of Preoperative 18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study , 2012, Journal of breast cancer.

[5]  J. Takita,et al.  Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. , 2005, Anticancer research.

[6]  L. Rybak,et al.  Radiological imaging for the diagnosis of bone metastases. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[7]  Jinming Yu,et al.  Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT. , 2010, European Journal of Radiology.

[8]  Mi Ra Kim,et al.  18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract. , 2008, Oral oncology.

[9]  Roberto Cardarelli,et al.  Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast Cancer , 2008, Clinical nuclear medicine.

[10]  G. Antoch,et al.  Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  M. Brandi,et al.  Physiopathological basis of bone turnover. , 2001, Quarterly Journal of Nuclear Medicine.

[12]  Han Wu,et al.  Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non–small‐cell lung cancer patients , 2013, International journal of cancer.

[13]  Z. Sajjad,et al.  Metastasis on bone scan with low prostate specific antigen (≤20 ng/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines? , 2011, Asian Pacific journal of cancer prevention : APJCP.

[14]  R. Wahl,et al.  CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. , 2005, Radiology.

[15]  Laurence Collette,et al.  Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? , 2012, European urology.

[16]  D. Groheux,et al.  Performance of FDG PET/CT in the clinical management of breast cancer. , 2013, Radiology.

[17]  M. Tulchinsky,et al.  False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer. , 2012, Clinical nuclear medicine.

[18]  G. Cook,et al.  Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial , 2013, The Journal of Nuclear Medicine.

[19]  P. Ell,et al.  Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Lalit Kumar,et al.  The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan , 2013, Japanese Journal of Radiology.

[21]  Ora Israel,et al.  Positron emission tomography and bone metastases. , 2005, Seminars in nuclear medicine.

[22]  D. Rubello,et al.  Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging. , 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.